Core Insights - Alpha Modus Holdings, Inc. has signed a pilot agreement with a major national retail chain to deploy approximately 100 AlphaCash financial service kiosks across Texas, marking the first entry of AlphaCash into retail stores [1][4] - The pilot aims to address the needs of underbanked consumers, with a significant portion of the population in areas like Houston being underbanked [4][6] - Alpha Modus has identified over 4,000 additional U.S. retail locations for potential expansion of AlphaCash, contingent on the pilot's success [3][7] Company Strategy - The pilot represents a material inflection point for Alpha Modus's financial services platform, with a conservative estimate of $2,000 in monthly revenue per kiosk [4] - The rollout will include coordinated joint-marketing efforts between Alpha Modus and the retailer, providing a unified public launch strategy [1][6] - AlphaCash kiosks will initially offer services such as Check Cashing, Money Transfer, Event Tickets, and Mobile Top-Up, with plans for additional services as adoption increases [5][6] Market Opportunity - The underbanked population in the U.S. is estimated at 4.2% of households, indicating a substantial market opportunity for accessible financial services [4] - The pilot will span both rural and metropolitan regions, targeting areas with high concentrations of underbanked consumers [1][4] - Alpha Modus is positioned for accelerated national-scale growth and expanded financial-access impact, leveraging its AI-driven fintech platform [7]

Core Viewpoint - XBP Global Holdings, Inc. has announced a 1-for-10 reverse stock split, effective December 12, 2025, to enhance its stock price and market perception [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was authorized by stockholders at the Annual Meeting on July 25, 2025, where every ten shares will be combined into one share [2]. - No fractional shares will be issued; stockholders entitled to fractional shares will receive cash based on the closing price on the effective date [2]. - Post-split, XBP Global will have approximately 11.75 million shares of common stock outstanding, with adjustments made to outstanding warrants, stock options, and other derivative securities [3]. Group 2: Company Overview - XBP Global is a multinational technology and services company specializing in intelligent workflows, with operations in 20 countries and around 11,000 employees [5]. - The company partners with over 2,500 clients, including many Fortune 100 companies, to facilitate hyper-automation and digital transformation [5][6].

Core Insights - Everything Blockchain Inc. (EBZT) is focusing on developing AI-driven products for digital asset markets, including a stablecoin engine and an AI Sports Odds Engine [1][3][9] Financial Filings and Share Structure - EBZT plans to file its Q3 2025 financial statements by December 15, 2025 - Approximately 6.5 million common shares were voluntarily surrendered, reducing total outstanding shares from 33.4 million to 26.7 million - No new shares were issued during the quarter, indicating no dilution for existing shareholders [2][3] Shift to AI-Powered Finance - The company is transitioning from a digital treasury model to an AI-powered finance platform to optimize capital movement in digital markets - The CloverMint platform is being developed to automate the management of digital dollars [3][4] CloverMint Stablecoin Engine - CloverMint targets the expanding stablecoin market, estimated at $250 billion in 2025, with potential growth to $500–750 billion and high-end projections nearing $2 trillion by 2028 - Capturing just 0.1% of a $1 trillion stablecoin market could manage approximately $1 billion in assets, presenting a significant growth opportunity for EBZT [5] AI Sports Odds Engine - EBZT has initiated the development of an AI Sports Odds Engine to price and trade sports prediction markets on Polymarket - The AI models analyze major sporting events to identify mispriced odds and build hedged positions to capitalize on these discrepancies - Historical strategies have shown annualized returns of up to 250% on limited capital allocations, indicating early proof-of-concept for AI in sports trading [6][7][8] Market Positioning - With a lean share structure and a pipeline of AI-driven products, EBZT is positioned as a differentiated early-stage AI investment in the OTC markets [9]

NORWALK, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the “Securities”). Each share of common stock and accompanying warrant to purchase one share of common stock are being sold together at a co ...

Core Insights - Amneal Pharmaceuticals announced positive interim results from its Phase 4 ELEVATE-PD study for CREXONT, a new treatment for Parkinson's disease, showcasing significant clinical benefits for patients [1][2]. Group 1: Study Results - The first 55 patients in the study showed substantial improvements after six weeks of treatment with CREXONT, including an increase in daily "Good On" time by 1.86 hours, a reduction in "Off" time by 0.77 hours, and an increase in "Good On" time per dose by 0.79 hours [3][4]. - The MDS-UPDRS total score improved by an average of -14.2 points, indicating enhanced motor function [4]. - CREXONT demonstrated a longer duration of benefit with each dose compared to other oral carbidopa/levodopa therapies, highlighting its differentiated clinical performance [4][5]. Group 2: Safety and Efficacy - Treatment-emergent adverse events (TEAEs) were generally mild to moderate, with common side effects including nausea (5.5%), falls (3.6%), dizziness (3.6%), and urinary tract infection (3.6%) [6]. - The ongoing ELEVATE-PD study aims to provide longer-term data and patient-reported outcomes in 2026, further supporting CREXONT's impact on motor symptom control and functional independence [6][8]. Group 3: Product Information - CREXONT is an innovative formulation that combines immediate-release granules and extended-release pellets, designed to optimize levodopa delivery and absorption, providing the longest-lasting plasma levels of any oral CD/LD therapy available [2][7]. - The ELEVATE-PD study is an open-label, multi-center clinical trial designed to evaluate the real-world efficacy and safety of switching to CREXONT in adults with moderately severe Parkinson's disease [8].

KING OF PRUSSIA, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, and CPA.com, the trusted partner in accounting and finance transformation, today announced an expansion of their partnership to include an AI-driven solution in collaboration with Kintsugi. The application helps accounting firms of all sizes and tax expertise deliver automated, accurate, and scalable sales tax compliance for clients. Building on ...

Quincy, MA, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced the launch of its Online Gifting Program, a customizable platform that enables clients to deliver their own branded gifting experiences to their customers. The scalable digital platform is designed to help clients recognize and reward their custo ...

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSXV: AOT.H; OTCID: AOTVF) (“Ascot” or the “Company”) advises shareholders that further to its news release of November 7, 2025, that the rights offering to raise gross proceeds of up to C$14,871,517 (the “Rights Offering”) described therein is set to expire at 5:00 pm (Toronto time) on Friday December 12, 2025 and subscriptions and subsc ...

Core Insights - CPI Aerostructures, Inc. announced the appointment of Dorith Hakim to the Executive Committee of the Aerospace Industry Association (AIA), which advocates for the U.S. aerospace and defense industry [1][2] Group 1: Company Overview - CPI Aero is a prime contractor to the U.S. Department of Defense and a Tier 1 subcontractor to major aerospace and defense contractors globally [3] - The company provides a range of services including engineering, program management, supply chain management, assembly operations, and MRO services [3] - CPI Aero is recognized for its capabilities in aircraft structural assemblies, military advanced tactical pod structures, engine air inlets, and complex welded products [3] Group 2: Industry Representation - Dorith Hakim emphasized the importance of representing CPI Aero, which is part of 96% of AS9100 Series Certified Small Businesses with fewer than 500 employees, in shaping policy alongside larger Prime/OEM A&D companies [2]

Core Insights - Lelantos Holdings, Inc. has engaged Aloba, Awomolo & Partners (AAP) to conduct financial audits in preparation for an uplisting to the OTCQB® Venture Market, aiming to enhance transparency and governance standards [1][2][4] Group 1: Company Overview - Lelantos Holdings is a diversified development company focused on renewable energy and high-value natural resource opportunities [1][6] - The company aims to operate as a vertically integrated entity to reduce overhead and increase service offerings in the sustainable energy sector [6] Group 2: Audit Engagement - AAP, a PCAOB-approved auditing firm, will perform independent audits of Lelantos Holdings' financial statements, aligning with PCAOB standards to support enhanced internal controls and transparency [2][4] - The engagement of AAP is seen as a key milestone in Lelantos Holdings' evolution as a public company, reflecting its commitment to institutional-grade governance [4] Group 3: Strategic Goals - The company believes that a successful uplist to OTCQB could improve trading liquidity, broaden its investor base, and increase visibility within capital markets [4] - AAP's experience in PCAOB-standard audits is expected to support Lelantos Holdings' objectives of elevating reporting practices and governance standards [4][5]